RAC 0.00% $1.69 race oncology ltd

AML market $400 million growing to $3.5 billion in 5 years., page-9

  1. 60 Posts.
    lightbulb Created with Sketch. 1

    I talked with a guy in the cancer biotech business. He said they will get partnered AML is very hot. Its just a matter of which big biotech wants in. They dont all like chemo drugs. But opportunistic ones do. So hes confident someone will do it. So this a stock to tuck away until a deal unfolds. So $1 on a deal is probable. I bet they raise a few bucks when stock goes over 1.00. But wont be much maybe 2 million.

    Last edited by biotechtrader73: 05/11/18
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.